<i>In Vitro</i> Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates-Reference-Cited by-同舟云学术

In Vitro Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates

Published:2022-08-31 Issue:4 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Mtshali Andile¹²^ORCID,Ngcapu Sinaye¹²,Govender Kavitha¹,Sturm A. Willem¹,Moodley Prashini¹,Joubert Bronwyn C.¹

Affiliation:

1. School of Laboratory Medicine and Medical Science, Department of Medical Microbiology, University of KwaZulu-Natal, KwaZulu-Natal, South Africa

2. Centre for the AIDS Programme of Research in South Africa, Durban, South Africa

Abstract

Trichomonas vaginalis is the most common nonviral sexually transmitted infection associated with reproductive sequelae and HIV acquisition risk worldwide. Despite its role in reproductive health, a high prevalence in South Africa, and the reported metronidazole resistance worldwide, no alternative regimens have been tested against T. vaginalis in our setting.

Funder

National Research Foundation

National Department of Health

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00912-22

Reference30 articles.

1. WHO. 2021. Global progress report on HIV viral hepatitis and sexually transmitted infections 2021. World Health Organization Geneva Switzerland.

2. Estimating prevalence and incidence of sexually transmitted infections among South African women: Implications of combined impacts of risk factors